CONSUN PHARMAC.GR.HD -10 Cash Flow Quality Index
CONSUN PHARMAC.GR.HD -10 cash flow quality index. CONSUN PHARMAC.GR.HD -10 (C1P) has a Cash Flow Quality Index of 1.12x as of December 2025. Operating cash flow of €1.21 Billion exceeds net income of €1.08 Billion, indicating high earnings quality where cash backs reported profits. See C1P financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Cash flow quality index of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. Historical Cash Flow Quality Index for CONSUN PHARMAC.GR.HD -10 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of CONSUN PHARMAC.GR.HD -10 to assess how comfortably operating cash covers total debt obligations.
CONSUN PHARMAC.GR.HD -10 Cash Flow Quality Index by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for CONSUN PHARMAC.GR.HD -10. For the full cash flow conversion analysis, see CONSUN PHARMAC.GR.HD -10 cash conversion from operations.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | €1.21 Billion | €1.08 Billion | ▼ -5.9% |
| 2024 | 1.19x | €1.09 Billion | €910.46 Million | ▲ +14.4% |
| 2023 | 1.04x | €818.97 Million | €784.53 Million | ▼ -24.8% |
| 2022 | 1.39x | €947.68 Million | €682.91 Million | ▲ +12.9% |
| 2021 | 1.23x | €725.54 Million | €590.17 Million | — |